BRWA
BLRX

B. Riley Wealth Advisors’s BioLineRX BLRX Stock Holding History

B. Riley Wealth Advisors’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-533
Closed -$38.8K – 1409
2024
Q1 		$38.8K Buy
533
+51
+11% +$2.56K ﹤0.01% 1410
2023
Q4 		$30.3K Sell
482
-51
-10% -$3.15K ﹤0.01% 1361
2023
Q3 		$38.8K Buy
533
+250
+88% +$16.8K ﹤0.01% 1410
2023
Q2 		$18K Buy
+283
New +$15.7K ﹤0.01% 1513

Other funds holding BLRX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

B. Riley Wealth Advisors's BLRX Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of BioLineRX (BLRX) in Q2 2024, closing a stake of 533 shares — an estimated $38.8K sold.

B. Riley Wealth Advisors first reported a position in BLRX in Q2 2023 and held it in 4 quarters. The position peaked at $38.8K in Q1 2024. 31 funds tracked by Wall St. Rank hold BLRX as of Q2 2024.

  • B. Riley Wealth Advisors reported no remaining BioLineRX position as of Q2 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 533 BioLineRX shares in Q2 2024, an estimated $38.8K.
  • B. Riley Wealth Advisors first reported a position in BioLineRX in Q2 2023 and held it in 4 quarters.
  • B. Riley Wealth Advisors's BioLineRX position peaked at $38.8K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.